"In terms of the historical development of this intervention, the first supervised drug consumption room was opened in Berne, Switzerland in June 1986. Further facilities of this type were established in subsequent years in Germany, the Netherlands, Spain, Norway, Luxembourg, Denmark, Greece and France. A total of 78 official drug consumption facilities currently operate in seven EMCDDA reporting countries, following the opening of the first two drug consumption facilities in the framework of a 6-year trial in France in 2016.

"Breaking this down further, as of February 2017 there are: 31 facilities in 25 cities in the Netherlands; 24 in 15 cities in Germany; five in four cities in Denmark 13 in seven cities in Spain; two in two cities in Norway; two in two cities in France; and one in Luxembourg (Luxembourg is preparing to open a second facility in 2018); and 12 in eight cities in Switzerland. In Slovenia following a change in the penal code that created an enabling environment for the opening of supervised consumption facilities, a planned pilot project is pending.

"In 2018, 205,000 people aged 12 or older initiated methamphetamine use in the past year (Figures 26 and 30), which averages to about 560 people per day who initiated methamphetamine use (Table A.3A). The number of past year initiates in 2018 for methamphetamine use was similar to the numbers in 2015 to 2017. In 2018, an estimated 31,000 adolescents aged 12 to 17 used methamphetamine for the first time in the past year (Figure 30). The number of adolescents in 2018 who were methamphetamine initiates was similar to the numbers in 2015 to 2017.

"In 2018, approximately 1.9 million people aged 12 or older used methamphetamine in the past year (Figure 10). This number of past year methamphetamine users corresponds to 0.7 percent of the population (Figure 15). The percentage of people aged 12 or older in 2018 who used methamphetamine in the past year was similar to the percentages in 2015 and 2017, but it was slightly higher than the percentage in 2016 (0.5 percent)."

"What is methamphetamine?
"Methamphetamine is a stimulant drug usually used as a white, bitter-tasting powder or a pill. Crystal methamphetamine is a form of the drug that looks like glass fragments or shiny, bluish-white rocks. It is chemically similar to amphetamine [a drug used to treat attention-deficit hyperactivity disorder (ADHD) and narcolepsy, a sleep disorder].

"Other common names for methamphetamine include chalk, crank, crystal, ice, meth, and speed.